Chylomicronemia can be due to genetic causes (Type 1) or both genetic and secondary factorsÂ  (Type 5) such as in adults. The most significant risk is for pancreatitis. Novel therapies such inhibition of apoCIII could greatly improve the treatment of familial chylomicronemia syndrome in the future.